Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
"Merck Serono, Merck Healthcare Pty Ltd",Cladribine,relapsing-remitting multiple sclerosis,Cladribine,Only if cost neutral or cost saving,,Nervous System
